<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article         dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>ktd</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Kocatepe Tıp Dergisi</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">3061-9904</issn>
                                                                                            <publisher>
                    <publisher-name>Afyonkarahisar Sağlık Bilimleri Üniversitesi</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id/>
                                                                                                                                                                                            <title-group>
                                                                                                                        <trans-title-group xml:lang="en">
                                    <trans-title>Ketiapin Zehirlenmesi ile Nöroleptik Malign Sendromun Ayırıcı Tanısındaki Güçlükler</trans-title>
                                </trans-title-group>
                                                                                                                                                                                                <article-title>Ketiapin Zehirlenmesi ile Nöroleptik Malign Sendromun Ayırıcı Tanısındaki Güçlükler</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                <name>
                                    <surname>Çekiç</surname>
                                    <given-names>Bahanur</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Geze</surname>
                                    <given-names>Şükran</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Yılmaz</surname>
                                    <given-names>Ali Alkan</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Özdemir</surname>
                                    <given-names>Asiye</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Ulusoy</surname>
                                    <given-names>Hülya</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Beşir</surname>
                                    <given-names>Ahmet</given-names>
                                </name>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20140801">
                    <day>08</day>
                    <month>01</month>
                    <year>2014</year>
                </pub-date>
                                        <volume>15</volume>
                                        <issue>2</issue>
                                                
                        <history>
                                    <date date-type="received" iso-8601-date="20150508">
                        <day>05</day>
                        <month>08</month>
                        <year>2015</year>
                    </date>
                                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 1999, Kocatepe Tıp Dergisi</copyright-statement>
                    <copyright-year>1999</copyright-year>
                    <copyright-holder>Kocatepe Tıp Dergisi</copyright-holder>
                </permissions>
            
                                                                                                <trans-abstract xml:lang="en">
                            <p>Quetiapine is atypical antipsychotic agent that is widely used for the treatment of depression, bipolar disorder and schizophrenia. characterized by hyperthermia, muscle rigidity, altered mental status, autonomic dysfunction, leukocytosis and elevation of creatinine phosphokinase. NMS is rare but lifethreatening complication of antipsychotic treatment. In this report we emphasized the difficulties in the differential diagnosis of NMS with quetiapine poisoning</p></trans-abstract>
                                                                                                                                    <abstract><p>Ketiapin depresyon, bipolar bozukluk ve şizofreni tedavisi için yaygın olarak kullanılan atipik antipsikotik bir ajandır. Nöroleptik malign sendrom (NMS) hipertermi, kas rijiditesi, otonomik disfonksiyon, mental durum değişikliği, lökositoz ve creatinin fosfokinaz yüksekliği ile karakterizedir. NMS antipsikotik tedavinin nadir ama hayati tehdit eden bir komplikasyonudur.Bu olgu sunumunda biz ketiapin zehirlenmesi ile NMS’nin ayırıcı tanısında yaşanan güçlükleri vurgulamak istedik</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>Ketiapin zehirlenmesi; nöroleptik malign sendrom; hipertermi</kwd>
                                            </kwd-group>
                            
                                                <kwd-group xml:lang="en">
                                                    <kwd>Quetiapine poisoning; neuroleptic malignant syndrome; hyperthermia</kwd>
                                            </kwd-group>
                                                                                                                                        </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">Balit CR, Isbister GK, Hackett LP, et al. Quetiapine poisoining: a case series. Ann Emerg Med 2003;42(6):751-8.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">Yumru M, Savaş HA,Savaş E. Tek doz klorpromazin uygulaması sonrası gelişen ve elektrokonvulsif tedavi- ye olumlu yanıt veren nöroleptik malign sendrom: olgu sunumu. Türkiye&#039;de Psikiyatri 2005;7(3):126-8.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">Trollor JN, Sachdev PS. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry 1999;33(5):650</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Chandran GJ, Mikler JR, Keegan DL. Neuroleptic malignant syndrome: case report and discussion. CMAJ 2003;169(5):439-42.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Saka MC, Can S, Özgüven HD, Atbaşoğlu EC. Antipsikotik ilaçların yan etkileri. Türkiye Klinikleri Dahili Tıp Bilimleri Dergisi Psikiyatri 2005;1(12):58-66.</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">Pollak PT, Zbuk K. Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions. Clin Pharmacol Ther 2000;68(1):92-7.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Courey TJ, McIntyre LJ. The nurse practitioner’s role in early detection and management of neuroleptic malignant syndrome. Journal for Nurse Practitioners 2006;2(7):460–3.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Harrison PA, McErlane KS. Neuroleptic malignant syndrome. 2008;108(7):35–8. Journal of Nursing</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">Susman VL. Clinical management of neuroleptic malignant 2001;72(4):325–36. Psychiatric Quarterly</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
